Form 4: Director Paul Bisaro Receives Myriad Genetics Equity Grant

Director Paul Bisaro was granted 59,701 restricted stock units in Myriad Genetics, Inc. as part of the 2026 equity incentive plan.

Summary

• Director Paul Bisaro acquired 59,701 restricted stock units (RSUs) on June 4, 2026.
• The grant was issued under the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan.
• Each RSU represents a contingent right to receive one share of common stock.
• The total beneficial ownership for the director following this transaction is 157,142 shares.
• The RSUs vest on the earlier of the first anniversary of the grant or the date of the next annual stockholders meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard equity incentive grant consistent with corporate governance practices.

Negatives

• None identified.

Risks

• Market volatility affecting the future value of the granted equity.

Future Outlook

The RSUs are subject to vesting conditions based on the passage of time or the next annual meeting of stockholders.

Industry Context

StockSavvy.ai notes that director equity grants are standard practice in the biotechnology sector to ensure long-term alignment between board members and company performance.

Comparison to Industry Standards

• The grant structure follows standard industry practices for director compensation in mid-cap biotechnology firms.
• Vesting schedules tied to annual meetings are common among US-listed life sciences companies.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased alignment of director incentives with long-term stock performance.

Next Steps

• Vesting of the 59,701 RSUs on the earlier of the first anniversary or the next annual meeting.

Key Dates

Keywords

Myriad Genetics, MYGN, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation